Biofrontera Inc. Impairment of Intangible Assets, Finite-lived
Biofrontera Inc. (BFRI) reported Impairment of Intangible Assets, Finite-lived of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2026-08-13
- Biofrontera Inc. impairment of intangible assets, finite-lived for the quarter ending 2026-06-30 was $0.00.
- Biofrontera Inc. impairment of intangible assets, finite-lived for the quarter ending 2025-06-30 was $0.00.
- Biofrontera Inc. impairment of intangible assets, finite-lived for the quarter ending 2025-03-31 was $0.00.
- Biofrontera Inc. impairment of intangible assets, finite-lived for fiscal 2025 was $0.00.
- Biofrontera Inc. impairment of intangible assets, finite-lived for fiscal 2024 was $0.00.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $0.00 10-K · filed 2026-03-19 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |